Skip to content

Talphera, Inc. TLPH Accounts Payable

Accounts Payable at other companies

Baxter International logo
Baxter InternationalBAX
$102M+538%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$3.1M+88.1%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX

Other financials

Income statement

See full
Revenue--100%
Gross profit-$1.9M-52.7%
Operating income-$3.9M-35.4%
Net income-$2.6M+1.4%
EPS (diluted)-$0.10+37.5%

Balance sheet

See full
Cash & equivalents$3.8M-29.0%
Total debt$3.4M-79.7%
Total equity$18.5M+230%
Total assets$30.2M+101%

Cash flow

See full
Operating cash flow-$3.4M+2.0%
CapEx-
Free cash flow-$2.3M+42.9%

Valuation

See full
Market cap$53.46M+516%
P/S53,456.6×+53,135×

Profitability

See full
Gross margin-127.7%-136pp
Operating margin-1,451,600%-1,507,145pp
Net margin-1,425,300%-1,471,200pp
FCF margin-5,116.7%-6,779pp

Returns & leverage

See full
Return on equity-118.4%+15.4pp
Debt / equity0.2×
Current ratio5.3×+2.2×

Where this comes from

Reported directly by Talphera, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: Talphera, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Talphera, Inc.'s accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Talphera, Inc.'s accounts payable?
Talphera, Inc. (TLPH) reported accounts payable of $210K in Q1 2026.
How has Talphera, Inc.'s accounts payable changed year-over-year?
Talphera, Inc.'s accounts payable increased by 160.9% year-over-year, from -$345K to $210K.